DataMeds AI Inc. (MEDS)
NASDAQ
3.76
-0.88 (-18.97%)
Closed
Sep 18, 2026
Day's Range
3.456.29
52 wk Range
0.823075.00
Financial Statements - MEDS - DataMeds AI Inc.
Revenue
23.33M▲ 182.1%
Net Income
-101.27M▼ 467.6%Net Margin -433.9%
EBITDA
-77.94M▼ 1158.2%
Free Cash Flow
-11.73M▼ 466.0%
Income Statement
| Period Ending | 2025-12-31 | 2023-12-31 |
|---|---|---|
| Sales | 23.33M | 8.27M |
| Cost of Goods | 29.76M | 5.67M |
| Gross Profit | -6.42M | 2.59M |
 Operating Expense | - | - |
| Operating Income | -81.19M | -7.26M |
| Non-Operating Interest | - | - |
| Other Income Expense | -15.50M | -5.26M |
| Pre Tax Income | -101.27M | -13.72M |
| Income Tax | 0 | - |
| Net Income | -101.27M | -17.84M |
| EPS Basic | -71.5 | -23.35 |
| EPS Diluted | -71.5 | -23.35 |
| Basic Shares Outstanding | 1.41M | 764.05K |
| Diluted Shares Outstanding | 1.41M | 764.05K |
| Ebit | -96.69M | -12.52M |
| Ebitda | -77.94M | -6.19M |
| Net Income Continuous Operations | -101.27M | -13.72M |
| Minority Interests | - | 0 |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
